Vyome Holdings, Inc. (HIND)
$1.93-2.03%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- 1.54
- P/E (TTM)
- -0.06
- Short % float
- 1.30%
- Days to cover
- 1.0
- SI change
- +21.9%
- 1W
- -5.39%
- 1M
- -3.98%
- vs SPY 1W
- -5.25%
- vs SPY 1M
- -6.49%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 6
- GROWTH
- 8
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-152.8%
REV YoY-
ROE-254.6%
EPS YoY-
ROA-123.2%
GROSS46
OP-3250
NET-8717
[VALUATION]
P/E TTM-0.06
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B2.24
P/FCF-
EV/EBITDA-0.49
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.29
ALTMAN Z-
CURR RATIO4.37
ND/EBITDA-
BETA1.54
Company news
FAQ
- What is LOPJLB’s current signal on HIND?
- LOPJLB’s latest quantitative signal on Vyome Holdings, Inc. (HIND) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is HIND in?
- Vyome Holdings, Inc. (HIND) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Vyome Holdings, Inc. (HIND) do?
- Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.